Diurnal Group PLC Director Dealings (5835Q)
21 Oktober 2019 - 2:09PM
UK Regulatory
TIDMDNL
RNS Number : 5835Q
Diurnal Group PLC
21 October 2019
21 October 2019
Diurnal Group plc
("Diurnal" or the "Company")
Director Dealings
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical
company targeting patient needs in chronic endocrine (hormonal)
diseases, announces the following Directors' dealings undertaken
for tax planning purposes:
Martin Whitaker, Chief Executive Officer, exercised options over
424,500 ordinary shares of GBP0.05 each ("Ordinary Shares") at a
price of 0.2p pence per Ordinary Share and sold 230,152 Ordinary
Shares at a price of 26 pence per ordinary share in order to fund
the exercise price, income taxes, and to satisfy market demand for
shares following recent investor meetings. Martin Whitaker retained
194,348 Ordinary Shares.
Richard Ross, Chief Scientific Officer, exercised options over
1,349,000 Ordinary Shares at a price of 26 pence per Ordinary Share
and sold 731,386 Ordinary Shares at a price of 26 pence per
Ordinary Share in order to fund the exercise price, income taxes,
and to satisfy market demand for shares following recent investor
meetings. Richard Ross retained 617,614 Ordinary Shares.
John Goddard, Non-Executive Director of the Company, has been
issued and allotted 12,939 Ordinary Shares as part of a
pre-existing arrangement whereby he receives shares in the Company
in lieu of part of his Non-executive director fees
All Ordinary Shares were issued from the Company's Employee
Benefit Trust scheme.
Following the transactions, the total beneficial interest of
Martin Whitaker and his connected parties is 314,991 Ordinary
Shares, representing 0.36% of the total voting rights, the total
beneficial interest of Richard Ross and his connected parties is
2,182,420 Ordinary Shares, representing 2.53% of the total voting
rights, and the total beneficial interest of John Goddard and his
connected parties is 128,299 Ordinary Shares, representing 0.15% of
the total voting rights.
Details of the full notifications received by the Company are
set out below:
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Martin Whitaker
------------------------------- -------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------- -------------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
a) Description of the Ordinary shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Exercise of share options and sale
of ordinary shares
------------------------------- -------------------------------------------
c) Price(s) and volume(s)
----------------- ------------
Price(s) Volume(s)
----------------- ------------
Exercise 0.2p 424,500
Sales 26p 230,152
------------------------------------------------------------ ------------
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 21 October 2019
------------------------------- -------------------------------------------
f) Place of the transaction XLON
------------------------------- -------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Ross
------------------------------- -------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
a) Position/status Chief Scientific Officer
------------------------------- -------------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------- -------------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
a) Description of the Ordinary shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Exercise of share options and sale
of ordinary shares
------------------------------- -------------------------------------------
c) Price(s) and volume(s)
------------------ ------------
Price(s) Volume(s)
------------------ ------------
Exercise 0.2p 1,349,000
Sales 26p 731,386
------------------------------------------------------------- ------------
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 21 October 2019
------------------------------- -------------------------------------------
f) Place of the transaction XLON
------------------------------- -------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name John Goddard
------------------------------------- -----------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------
a) Position/status Non-executive Director
------------------------------------- -----------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------
a) Name Diurnal Group plc
------------------------------------- -----------------------------------------
b) LEI 213800I2HNUNZN1LDH29
------------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------------
a) Description of the Ordinary shares of 5 pence each in
financial instrument, Diurnal Group plc
type of instrument
Identification code GB00BDB6Q760
b) Nature of the transaction Acquisition of ordinary shares
------------------------------------- -----------------------------------------
c) Price(s) and volume(s)
------------------- -----------------
Price(s) Volume(s)
------------------- -----------------
Nil 12,939
-------------------------------------------------------------- -----------------
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 21 October 2019
------------------------------------- -----------------------------------------
f) Place of the transaction XLON
------------------------------------- -----------------------------------------
For further information, please visit www.diurnal.co.uk or contact:
+44 (0)20 3727
Diurnal Group plc 1000
Martin Whitaker, Chief Executive Officer
Richard Bungay, Chief Financial Officer
Panmure Gordon (UK) Limited (Nominated Adviser +44 (0) 20 7886
and Joint Broker) 2500
Corporate Finance: Freddy Crossley, Emma Earl
Corporate Broking: James Stearns
+44 (0)20 7894
Cantor Fitzgerald Europe (Joint Broker) 7000
Corporate Finance: Phil Davies, Will Goode,
Michael Boot
Healthcare Equity Sales: Andrew Keith
+44 (0)20 3727
FTI Consulting (Media and Investor Relations) 1000
Simon Conway
Victoria Foster Mitchell
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company
developing high quality products for the global market for the
life-long treatment of chronic endocrine conditions, including
Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its
expertise and innovative research activities focus on
circadian-based endocrinology to yield novel product candidates in
the rare and chronic endocrine disease arena.
For further information about Diurnal, please visit
www.diurnal.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLLFIFIRLLFIA
(END) Dow Jones Newswires
October 21, 2019 08:09 ET (12:09 GMT)
Diurnal (LSE:DNL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Diurnal (LSE:DNL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
